- 1) Lipid research clinics program, The lipid research clinics coronary primary prevention trial results, I: reduction in incidence of coronary heart disease. J. Am. Med. Assoc., 251, 351–364 (1984).
- 2) Levine, G. N., Keaney, J. F., and Vita, J. A., Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N. Engl. J. Med., 332, 512–521 (1995).
- 3) Patsch, J. R., Miesenbock, G., Hopferwieser, T., Muhlberger, V., Knapp, E., Dunn, J. K., Gotto Jr., A. M., and Patsch, W., Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb., 12, 1336–1345 (1992).
- 4) Akuzawa, K., Nakano, T., Sekiguchi, I., Shimoyama, M., Adachi, M., Tange, S., Tanaka, A., Tada, N., and Nakajima, K., Remnant-like particles-cholesterol (RLP-C) assay and its clinical application to lipid tests in a postprandial as well as fasting state. Jpn. J. Clin. Pathol., 43, 1159–1167 (1995).
- 5) Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., and Manninen, V., Helsinki heart study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med., 317, 1237–1245 (1987).
- 6) Chen, W., and Anderson, J. W., Effects of guar gum and wheat bran on lipid metabolism of rats. J. Nutr., 109, 1028–1034 (1979).
- 7) Ide, T., Moriuchi, H., and Nihimoto, K., Hypolipidemic effects of guar gum and its enzyme hydrolysate in rats fed highly saturated fat diets. Ann. Nutr. Metab., 35, 33–44 (1991).
- 8) Yamatoya, K., Kuwano, K., and Suzuki, J., Effects of hydrolyzed guar gum on cholesterol and glucose in humans. Food Hydrocolloids, 11, 239–242 (1997).
- 9) Irie, N., Hara, T., and Goto, Y., The effects of guar gum on postprandial chylomicronemia. Nutr. Rep., 26, 207–214 (1982).
- 10) Yamatoya, K., Sekiya, K., Yamada, H., and Ichikawa, T., Effects of partially hydrolyzed guar gum on postprandial plasma glucose and lipid levels in humans. Nippon Eiyo Shokuryo Gakkaishi (in Japanese), 46, 199–203 (1993).
- 11) Xiao, J. Z., Kondo, S., Takahashi, N., Miyaji, K., Oshida, K., Hiramatsu, A., Iwatsuki, K., Kokubo, S., and Hosono, A., Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J. Dairy Sci., 86, 2452–2461 (2003).
- 12) Yamamoto, T., Tamamoto, S., Miyahara, I., Matsumura, Y., Hirata, A., and Kim, M., Isolation of a β-mannan hydrolyzing enzyme and hydrolysis of guar gum by the enzyme isolated. Denpun Kagaku (in Japanese), 37, 99–105 (1990).
- 13) Nakajima, K., Saito, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E., and Havel, R. J., Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin. Chim. Acta, 223, 53–71 (1993).
- 14) Nakamura, H., Ikewaki, K., Nishiwaki, M., and Shige, H., Postprandial hyperlipemia and coronary artery disease. Ann. New York Acad. Sci., 748, 441–446 (1995).
- 15) Simpson, H. S., Williamson, C. M., Olivecrona, T., Pringle, S., Maclean, J., Lorimer, A. R., Bonnefous, F., Bogaievsky, Y., Packard, C. J., and Shepherd, J., Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis, 85, 193–202 (1990).
Bioscience, Biotechnology, and Biochemistry
Volume 68, 2004 - Issue 5